Skip to content

OptimizeRx OPRX Change in Deferred Revenue

Change in Deferred Revenue at other companies

Spok Holdings logo
Spok HoldingsSPOK
-$2.19M-38.6%
Veeva Systems logo
Veeva SystemsVEEV
-$32.96M+20.3%
Phreesia logo
PhreesiaPHR
-$8.32M-414%
Doximity logo
DoximityDOCS
-$33.82M-37.3%
Spectral AI, Inc. logo
Spectral AI, Inc.MDAI
-$154K+48.1%
National Research Corporation logo
National Research CorporationNRC
$935K+428%

Other financials

Income statement

See full
Revenue$19.8M-9.5%
Gross profit$14.9M+11.9%
Operating income$396.0K+119%
Net income-$495.0K+77.5%
EPS (diluted)-$0.03+75.0%

Balance sheet

See full
Cash & equivalents$20.2M+21.7%
Total debt$23.7M-27.7%
Total equity$129.6M+11.5%
Total assets$167.3M-0.3%

Cash flow

See full
Operating cash flow-$467.0K-112%
CapEx$21.0K-22.2%
Free cash flow-$488.0K-113%

Valuation

See full
Market cap$107.34M-50.4%
Enterprise value$110.88M-51.4%
P/E15.7×
P/S-1.1×

Profitability

See full
Gross margin70%+14.1pp
Operating margin13.2%
Net margin6.4%+3.6pp
FCF margin13.4%+4.8pp

Returns & leverage

See full
Return on equity5.6%+3.3pp
Debt / equity0.2×-0.1×
Current ratio5.4×+2.6×

Where this comes from

Reported directly by OptimizeRx in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInContractWithCustomerLiability.

The official record: OptimizeRx’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about OptimizeRx's change in deferred revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OptimizeRx's change in deferred revenue?
OptimizeRx (OPRX) reported change in deferred revenue of $166K in Q1 2026.
How has OptimizeRx's change in deferred revenue changed year-over-year?
OptimizeRx's change in deferred revenue increased by 336.8% year-over-year, from $38K to $166K.
What does change in deferred revenue mean?
Change in payments received from customers for goods/services not yet delivered — a key SaaS and subscription metric.